New psychoactive substances (NPS) remain a global public health and clinical challenge. Popular NPS include synthetic cannabinoids (SCs). A conceptual metaphorical analysis of user experiences of SCs was conducted in two European countries (Western and Central European). Metaphors are increasingly used to better understand drug user experiences and as medium to inform and guide clinical responses. Semi-structured interviews with 12 SC users were conducted in Hungary (n = 6) and Ireland (n = 6). Thematically segmented texts of SC usage (1) motivation, (2) effects, (3) consequences and (4) the setting were selected. A systematic analysis of conceptual metaphors was conducted on the selected texts. The conceptual target and source domains of the experiences of SC usage (motivation, effects, consequences) were analysed. Four conceptual source domains were found in all of the segmented and analysed narratives of psychological factors (motivations, effects, consequences): change in the vertical perception, perceiving that SC is everywhere, feeling disconnected, recognition of lack of control and identifying the SC as a destroying entity. The conceptual metaphors reflect how users perceive experiences of SC use, the discrepancy between the experience of embodiment and disembodiment. This study provides clinicians with an insight into the experiences of SC motivations, effects and consequences and can be used to inform and guide clinical and therapeutic responses in the support of those recovering from SC dependence.
Barnard, M., Russell, C., McKeganey, N., & Hamilton-Barclay, T. (2017). The highs and lows of NPS/“legal high” use: qualitative views from a UK online survey. Drugs: Education, Prevention and Policy, 24(1), 96–102.
Corazza, O., Assi, S., Simonato, P., Corkery, J., Bersani, F. S., Demetrovics, Z., et al. (2013). Promoting innovation and excellence to face the rapid diffusion of novel psychoactive substances in the EU: the outcomes of the ReDNet project. Human Psychopharmacology: Clinical and Experimental, 28(4), 317–323. CrossRef
Dolengevich-Segal, H., Rodríguez-Salgado, B., Gómez-Arnau, J., & Sánchez-Mateos, D. (2017). An approach to the new psychoactive drugs phenomenon. Salud Mental, 40(2), 71–82. CrossRef
Dresen, S., Kneisel, S., Weinmann, W., Zimmermann, R., & Auwärter, V. (2011). Development and validation of a liquid chromatography–tandem mass spectrometry method for the quantitation of synthetic cannabinoids of the aminoalkylindole type and methanandamide in serum and its application to forensic samples. Journal of Mass Spectrometry, 46(2), 163–171. PubMedCrossRef
EMCDDA. (2015). New psychoactive substances in Europe. An update from the EU Early Warning System, http://www.emcdda.europa.eu/system/files/publications/65/TD0415135ENN.pdf. Accessed 05 July 2016.
European Monitoring Centre for Drugs and Drug Addiction – EMCDDA. (2009). Thematic paper—understanding the ‘spice’ phenomenon. Office for Official Publications of the European Communities, Luxembourg. Available via DIALOG. http://www.emcdda.europa.eu/attachements.cfm/att_80086_EN_EMCDDA_Understanding%20the%20‘Spice’%20phenomenon_4Update%2020090813.pdf. Accessed 30 May 2017.
Gerçek, C. (2017). The evaluation of students’ mental images of cigarette through metaphor analysis. Eurasia Journal of Mathematics, Science & Technology Education, 13(1), 105–111. CrossRef
Gibbs Jr., R. W. (2006). Metaphor interpretation as embodied simulation. Mind & Language, 21(3), 434–458. CrossRef
Gryczynski, J., Johnson, J., & Coyhis, D. (2007). The healing forest metaphor revisited: the seen and “unseen world” of drug use. Substance Use & Misuse, 42(2–3), 475–484. CrossRef
Gunderson, E. W., Haughey, H. M., Ait-Daoud, N., Joshi, A. S., & Hart, C. L. (2012). “Spice” and “K2” herbal highs: a case series and systematic review of the clinical effects and biopsychosocial implications of synthetic cannabinoid use in humans. The American Journal on Addictions, 21(4), 320–326. PubMedCrossRef
Hudson, S., Ramsey, J., King, L., Timbers, S., Maynard, S., Dargan, P. I., & Wood, D. M. (2010). Use of high-resolution accurate mass spectrometry to detect reported and previously unreported cannabinomimetics in “herbal high” products. Journal of Analytical Toxicology, 34(5), 252–260. PubMedCrossRef
Johnson, M., & Lakoff, G. (2002). Why cognitive linguistics requires embodied realism. Cognitive Linguistics, 13(3), 245–264. CrossRef
Kaló, Z. S., Vida, K., Gogibedasvili, A., Van Hout, M. C., & Rácz, J. (2013). English-Hungarian comparative study on metaphors of intravenous mephedrone use . European Society for Social Drug Research Annual Conference, Stockholm.
Kassai, S., Pintér, J. N., Rácz, J., Erdősi, D., Milibák, R., & Gyarmathy, V. A. (2017b). Using interpretative phenomenological analysis to assess identity formation among users of synthetic cannabinoids. International Journal of Mental Health and Addiction, 15(5), 1047–1054. CrossRef
Kjellgren, A., & Jonsson, K. (2013). Methoxetamine (MXE) – A phenomenological study of experiences induced by a “Legal High” from the internet. Journal of Psychoactive Drugs, 45(3), 276–286. https://doi.org/10.1080/02791072.2013.803647.
Kövecses, Z. (2003). Metaphor and emotion: language, culture, and body in human feeling. Cambridge: Cambridge University Press.
Kovecses, Z. (2010). Metaphor: a practical introduction. New York: Oxford University Press.
Lakoff, G., & Johnson, M. (1980). Metaphors we live by. University of Chicago press.
MacLachlan, M. (2004). Disembodied language. In M. MacLachlan (Ed.), Embodiment. Clinical, critical and cultural perspectives on health and illness (26-27). Open University Press.
Merleau-Ponty, M. (2002). Phenomenology of perception. London: Routledge. CrossRef
Meshack, A., Peters Jr., R. J., Lin, M. T., Hill, M., Abughosh, S., Essien, E. J., & Savage, C. (2013). The beliefs of teenage male cannabinoid users: a qualitative study. American Journal of Health Studies, 28(3).
Moser, K. S. (2000). Metaphor analysis in psychology—method, theory, and fields of application. In Forum Qualitative Sozialforschung/Forum: Qualitative Social Research (Vol. 1, no. 2).
Rácz J., & Kaló, Z. S. (2009). Metaforák és pszichoaktív anyaghasználat. [Metaphors and psychoactive substance use] Korunk, Retrived from: http://www.korunk.org/?q=node/8&ev=2009&honap=7&cikk=10870. Access date: 2017–07-09.
Rácz, J., Csák, R., Tóth, K. T., Tóth, E., Rozmán, K., & Gyarmathy, V. A. (2016). Veni, vidi, vici: the appearance and dominance of new psychoactive substances among new participants at the largest needle exchange program in Hungary between 2006 and 2014. Drug and Alcohol Dependence, 158, 154–158. PubMedCrossRef
Reitox National Focal Point. (2016). National Report to the EMCDDA, R.N.F. Point, 2016. http://drogfokuszpont.hu/wp-content/uploads/HU_National_Report_2016.pdf. Accessed 18 Jan 2017.
Roussel, O., Carlin, M. G., Bouvot, X., & Tensorer, L. (2015). The emergence of synthetic cannabinoids in Mayotte. Toxicologie Analytique et Clinique, 27(1), 18–22. CrossRef
Schifano, F., Corazza, O., Deluca, P., Davey, Z., Di Furia, L., Farre’, M., et al. (2009). Psychoactive drug or mystical incense? Overview of the online available information on spice products. International Journal of Culture and Mental Health, 2(2), 137–144. CrossRef
Schmitt, R. (2005). Systematic metaphor analysis as a method of qualitative research. The Qualitative Report, 10(2), 358–394.
Shinebourne, P., & Smith, J. A. (2010). The communicative power of metaphors: an analysis and interpretation of metaphors in accounts of the experience of addiction. Psychology and Psychotherapy: Theory, Research and Practice, 83(1), 59–73. CrossRef
Soussan, C., & Kjellgren, A. (2014). The flip side of “spice”: the adverse effects of synthetic cannabinoids as discussed on a Swedish internet forum. Nordic Studies on Alcohol and Drugs, 31(2), 207–220. CrossRef
Tung, C. K., Chiang, T. P., & Lam, M. (2012). Acute mental disturbance caused by synthetic cannabinoid: a potential emerging substance of abuse in Hong Kong. East Asian Archives of Psychiatry, 22(1), 31–33. PubMed
Tuv, S. S., Strand, M. C., Karinen, R., Øiestad, E. L., Christophersen, A. S., & Vindenes, V. (2012). Effect and occurrence of synthetic cannabinoids. Tidsskrift for den Norske laegeforening: tidsskrift for praktisk medicin, ny raekke, 132(20), 2285–2288. CrossRef
UNODC. (2013). The challenge of new psychoactive substances. A Report from the Global SMART Program. Available at: https://www.unodc.org/documents/scientific/NPS_2013_SMART.pdf. Retrived: 22-04-2018.
Van Hout, M. C. (2017). The dynamic landscape of novel psychoactive substance (NPS) use in Ireland: results from an expert consultation. International Journal of Mental Health and Addiction, 15(5), 985–992. CrossRef
Van Hout, M. C., & Brennan, R. (2011a). Plant food for thought: a qualitative study of mephedrone use in Ireland. Drugs: Education, Prevention and Policy, 18(5), 371–381.
Van Hout, M. C., & Brennan, R. (2011b). “Bump and grind”: an exploratory study of mephedrone users’ perceptions of sexuality and sexual risk. Drugs and Alcohol Today, 11(2), 93–103. CrossRef
Van Hout, M. C., & Brennan, R. (2012). Curiosity killed M-cat: a post-legislative study on mephedrone use in Ireland. Drugs: Education, Prevention and Policy, 19(2), 156–162.
Van Hout, M. C., & Hearne, E. (2017). User experiences of development of dependence on the synthetic cannabinoids, 5f-AKB48 and 5F-PB-22, and subsequent withdrawal syndromes. International Journal of Mental Health and Addiction, 15(3), 565–579. CrossRef
Wallace, B. (2004). Editorial. Addiction Research and Theory, 12(3), 195–199. CrossRef
Westphal, F., Junge, T., Sönnichsen, F., Rösner, P., & Schäper, J. (2010). Ein neuer Wirkstoff in SPICE-artigen Kräutermischungen: Charakterisierung von JWH-250, seinen methyl-und Trimethylsilylderivaten. [a new compound in herbal mixtures: characterisation of JWH-250, its methyl- and trimethylsilyl-derivatives]. Toxichem Krimtech, 77(1), 8–22.
- Synthetic Cannabinoids (SCs) in Metaphors: a Metaphorical Analysis of User Experiences of Synthetic Cannabinoids in Two Countries
Marie Claire Van Hout
- Springer US
International Journal of Mental Health and Addiction
Print ISSN: 1557-1874
Elektronische ISSN: 1557-1882